The independent source for health policy research, polling, and news.
101-120 of 4,007 results
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded. Meanwhile, researchers and doctors are concerned that some of these online companies aren't properly screening or monitoring patients. “It gives a black eye to telemedicine,” one researcher said.
Patients’ experiences encapsulate breakdowns in a healthcare system that traps patients in debt. The industry’s key players blame one another.
Last spring, a woman started exhibiting unusual memory problems after a hike in Arizona. It turns out she was experiencing a disorder called transient global amnesia. She has fully recovered, but a dispute over nearly $60,000 in hospital charges has been a source of stress for over a year.
When Republicans passed their big budget bill in 2025, they thought the effects of cuts to health programs wouldn’t show up until after the 2026 midterms. They were wrong. Meanwhile, the party is trumpeting its efforts to lower drug prices. Maya Goldman of Axios, Shefali Luthra of The 19th, and Lauren Weber of The Washington Post join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner discusses Ebola with KFF Health News’ Céline Gounder.
Conservative Shasta County stopped a measles outbreak from spreading, enlisting teachers, church leaders, and other trusted community members to get the public on board with health guidelines. Infectious disease specialists say the successful effort could be a guide for other communities struggling to contain the highly contagious virus.
RaDonda Vaught was convicted of negligent homicide for accidentally dispensing a deadly drug to a patient. She now gives speeches about hospital safety in an era of automation and artificial intelligence.
The state is ramping up to implement the federal work requirements six months ahead of the deadline. But Montana is one of several states already struggling to pay for health services.
KFF Health News gives readers a chance to comment on a recent batch of stories.
Congress' decision not to extend enhanced marketplace tax credits has boosted the appeal of alternative health coverage with lower monthly premiums. Consumer advocates dismiss the plans as "junk insurance,” while proponents say patients need alternatives to pricey marketplace options.
Get our weekly newsletter, The Week in Brief, featuring a roundup of our original coverage, Fridays at 2 p.m. ET.
Republicans promise that $50 billion in new health funding will help rural America. But it’s not expected to aid the years-long effort in North Carolina’s Martin County to reopen its only hospital.
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the list.
Podcast host Julie Rovner chats with Sen. Tammy Baldwin, a top Democrat on health issues, about President Donald Trump’s stewardship of federal spending and the effectiveness of the 988 Suicide & Crisis Lifeline.
A crisis pregnancy center in Sandpoint, Idaho, wants to expand women’s healthcare three years after the labor and delivery unit at the town’s hospital closed and its OB-GYNs moved out of state.
An uptick in people skipping Obamacare premium payments in many states suggests the Affordable Care Act’s rising costs — driven partly by lower subsidies to help people buy plans — are hitting home for 2026 enrollees. The trend adds to voter concerns about affordability ahead of the midterm elections.
Some children are healthy enough to leave the hospital after a medical stay but have no place to go. Across the country, the practice of allowing children to remain hospitalized “beyond medical necessity” has become a costly problem, and states have struggled to address the issue.
New ethics disclosures show the president invested in Eli Lilly and a company that manufactures injectable devices as his health agencies implemented policies that benefited them.
The work of Peter Aaby and Christine Stabell Benn has long been controversial. Until Robert F. Kennedy Jr. became the U.S. health policy chief, most vaccine scientists tended to ignore it. That has changed.
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
A Minnesota Star Tribune-KFF Health News investigation found charity care at hospitals in the state is offered at low and arbitrary levels, prompting Minnesota Attorney General Keith Ellison to say, “There is more work in front of us.”
© 2026 KFF